leukemia
Showing NaN - NaN of 135
Cognitive Aftereffects of Neurotoxicity in Children and Young
Not yet recruiting
- Lymphoma
- Leukemia
-
Los Angeles, California
- +2 more
Feb 2, 2023
Leukemia, Lymphoma Trial in United States (SCRI-CAR22v2)
Recruiting
- Leukemia
- Lymphoma
- SCRI-CAR22v2
-
Los Angeles, California
- +4 more
Jan 18, 2023
Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in
Suspended
- Juvenile Myelomonocytic Leukemia
- +27 more
- CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2023
Leukemia Trial in United States (arsenic trioxide, gemtuzumab ozogamicin, mercaptopurine)
Completed
- Leukemia
- arsenic trioxide
- +4 more
-
Roseville, California
- +191 more
Dec 14, 2022
Blood Samples to Identify Biomarkers of Busulfan
Active, not recruiting
- Leukemia
- +4 more
-
Seattle, WashingtonUniversity of Washington
Jan 4, 2023
Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma
Recruiting
- Clinical Stage I Cutaneous Melanoma AJCC v8
- +33 more
- Informational Intervention
- +4 more
-
Los Angeles, California
- +4 more
Dec 14, 2022
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR
Active, not recruiting
- Leukemia
- KIR genotyping
- HLA genotyping
-
Tampa, Florida
- +9 more
Nov 29, 2022
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)
Recruiting
- Leukemia
- +19 more
- CYNK-001
-
Denver, Colorado
- +9 more
Sep 9, 2022
Leukemia, Lymphoma Trial in Canada, United States (Patient-derived CD19- and CD22 specific CAR)
Recruiting
- Leukemia
- Lymphoma
- Patient-derived CD19- and CD22 specific CAR
-
Los Angeles, California
- +4 more
Apr 2, 2022
Leukemia, Precursor b-Cell Lymphoblastic Leukemia-Lymphoma, ACUTE LYMPHOBLASTIC LEUKEMIA Trial in Worldwide (inotuzumab
Active, not recruiting
- Leukemia
- +2 more
- inotuzumab ozogamicin-dose level 2
- Inotuzumab ozogamicin-dose level 1
-
Los Angeles, California
- +45 more
Mar 9, 2022
Leukemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (ibrutinib, venetoclax, Placebo)
Leukemia Trial in Seattle (Patient-derived CD22-specific CAR T-cells also expressing an EGFRt)
Active, not recruiting
- Leukemia
- Patient-derived CD22-specific CAR T-cells also expressing an EGFRt
-
Seattle, WashingtonSeattle Children's Hospital
Feb 15, 2022
Leukemia Trial in United States (cytarabine, idarubicin, pravastatin sodium)
Leukemia, Lymphoma Trial in Seattle (rituximab, fludarabine phosphate, pixantrone dimaleate)
Withdrawn
- Leukemia
- Lymphoma
- rituximab
- +2 more
-
Seattle, WashingtonCell Therapeutics, Incorporated
Oct 14, 2020
Breast Carcinoma, Cancer Survivor, Depression Trial in United States (procedure, other, behavioral)
Completed
- Breast Carcinoma
- +12 more
- Management of Therapy Complications
- +3 more
-
Los Angeles, California
- +5 more
Oct 8, 2020
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis, Seattle (biological,
Completed
- Acute Myeloid Leukemia
- +12 more
- filgrastim
- +6 more
-
Minneapolis, Minnesota
- +1 more
Sep 9, 2020
GVHD, Leukemia, MDS Trial in New Haven, Seattle (drug, radiation, other, procedure, biological)
Terminated
- Graft Versus Host Disease
- +2 more
- Fludarabine Phosphate
- +7 more
-
New Haven, Connecticut
- +1 more
Aug 10, 2020
Leukemia Trial in Canada, United States (rituximab, fludarabine phosphate)
Terminated
- Leukemia
- rituximab
- fludarabine phosphate
-
Anniston, Alabama
- +386 more
Apr 9, 2020
Leukemia Trial in Worldwide (biological, drug, procedure)
Unknown status
- Leukemia
- anti-thymocyte globulin
- +21 more
-
Boston, Massachusetts
- +12 more
Jul 29, 2019
Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in Seattle (aldesleukin)
Completed
- Leukemia
- +2 more
- aldesleukin
-
Seattle, WashingtonUniversity of Washington Medical Center
Feb 25, 2019
Aplastic Anemia, Leukemia, Myelodysplastic Syndrome Trial in United States (Busulfan, fludarabine, & cyclophosphamide with
Completed
- Aplastic Anemia
- +2 more
- Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.
- CliniMACS device
-
Boston, Massachusetts
- +5 more
Jun 14, 2018